IPO Readiness

Navigating a de-SPAC in 2026? Under strict timelines & strict 2024 SEC rules, execution is everything. Discover why disciplined project management across legal, audit, & governance is critical to protecting your transaction’s critical path & avoiding costly re-work.

How International Issuers can Evaluate Dual Listings, Up-Listings and Jurisdiction Strategy Across US & Canadian Markets. This edition builds directly on that framework by addressing the next strategic question confronting boards and executive teams once readiness and pathway have been considered: which jurisdiction should we choose – and in what sequence – to maximize long-term capital-markets success?

Companies evaluating public markets are often presented with multiple options: a traditional IPO, a Regulation A offering, a reverse merger, a SPAC transaction, or a Canadian exchange listing. Each of these is a listing pathway - a distinct regulatory and transactional route to becoming a public company - and each carries very different implications for governance, cost, timeline, investor base, and long-term credibility. This article introduces a stage-based IPO readiness an

Explore a strategic guide to NASDAQ, NYSE, TSX, TSXV, OTCQX, SPACs, CPCs & reverse mergers for your Initial Public Offering & stock exchange listing requirements. Many companies mistakenly believe that going public involves simply selecting a stock exchange & raising capital through an IPO. In reality, major markets like NASDAQ, NYSE, TSX, TSXV, OTCQX, SPACs & CPCs differ significantly in key areas that impact IPO process, listing requirements & long-term success, ie: ...